NOVO NORDISK INC. for NOVO NORDISK INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 18, 2017 | $1,270,000 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 19, 2017 | $1,270,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues related to scoring of preventive health; National Diabetes Prevention Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| AMANDA MAKKI | — |
| SARAH ELIZABETH NORDSTROM | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY WOTRING | — |
Trade (domestic/foreign) TRD
2017 Congressional trade agenda generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| AMANDA MAKKI | — |
| SARAH ELIZABETH NORDSTROM | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY WOTRING | — |
Taxation/Internal Revenue Code TAX
Comprehensive corporate tax reform, including border adjustment tax and interest deductibility
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| AMANDA MAKKI | — |
| SARAH ELIZABETH NORDSTROM | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY WOTRING | — |
Health Issues HCR
General diabetes prevention; H.R. 309 Clinical Care Commission Act; H.R. 1628 American Health Care Act (AHCA); H.R. 1776 / S.771 Improving Access To Affordable Prescription Drugs Act; World Hemophilia Day
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| AMANDA MAKKI | — |
| SARAH ELIZABETH NORDSTROM | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY WOTRING | — |
Pharmacy PHA
Issues related to Prescription Drug User Fee Act VI; issues related to 340B program; H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| AMANDA MAKKI | — |
| SARAH ELIZABETH NORDSTROM | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY WOTRING | — |
Medicare/Medicaid MMM
Medicare Diabetes Prevention Program and diabetes self-management education; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| AMANDA MAKKI | — |
| SARAH ELIZABETH NORDSTROM | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY WOTRING | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVO NORDISK FONDEN (ULTIMATE PARENT COMPANY) | Denmark | Denmark | 100.0% | — |
| NOVO A/S (OWNS 26.5% OF NN A/S) | Denmark | Denmark | 26.5% | — |
| REGISTRANT IS A WHOLLY-OWNED SUBSIDIARY OF NOVO NORDISK US WHICH IS WHOLLY-OWNED BY NOVO NORDISK A/S | Denmark | Denmark | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.